aluates Reports

$ 0.0

Automative

Global Hematologic Malignancies Detection Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-20M14708

Global Hematologic Malignancies Detection Market Research Report 2023

BUY CHAPTERS

Global Hematologic Malignancies Detection Market Research Report 2025

Code: QYRE-Auto-20M14708

Report

April 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Archerdx

Bio Rad Laboratories

Sysmex

Invitae

Neogenomics Laboratories

Abbott Laboratories

Cancer Genetics

Adaptive Biotechnologies Corporation

Asuragen

Invivoscribe

Annaroad Gene Technology

BGI Genomics

Nanjing Shihejiyin Technology

Hematologic Malignancies Detection Market Size

The global market for Hematologic Malignancies Detection was valued at US$ 2897 million in the year 2024 and is projected to reach a revised size of US$ 7426 million by 2031, growing at a CAGR of 14.6% during the forecast period.

Hematologic Malignancies Detection Market

Hematological malignancy is a major disease that seriously endangers human health. With the invention and application of polymerase chain reaction, immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization, its overall diagnostic level has been significantly improved.

Increasing prevalence of hematological malignancies, emerging new technologies and methods for testing, patient preference for testing treatments, and increasing regulation across the healthcare industry are the key factors driving the growth of hematological malignancies testing market revenue.

This report aims to provide a comprehensive presentation of the global market for Hematologic Malignancies Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematologic Malignancies Detection.

The Hematologic Malignancies Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hematologic Malignancies Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hematologic Malignancies Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hematologic Malignancies Detection Market Report

Report Metric	Details
Report Name	Hematologic Malignancies Detection Market
Accounted market size in year	US$ 2897 million
Forecasted market size in 2031	US$ 7426 million
CAGR	14.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Polymerase Chain Reaction Immunochemistry Next Generation Sequencing Fluorescence in Situ Hybridization Others
Segment by Application	Multiple Myeloma Myelodysplastic Syndrome Leukemia Myeloproliferative Neoplasms Lymphoma Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	ArcherDx, Bio-Rad Laboratories, sysmex, Invitae, NeoGenomics Laboratories, Abbott Laboratories, Cancer Genetics, Adaptive Biotechnologies Corporation, Asuragen, Invivoscribe, Nanjing Shihejiyin Technology, Annaroad Gene Technology, BGI Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematologic Malignancies Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Hematologic Malignancies Detection Market growing?

Ans: The Hematologic Malignancies Detection Market witnessing a CAGR of 14.6% during the forecast period 2025-2031.

What is the Hematologic Malignancies Detection Market size in 2031?

Ans: The Hematologic Malignancies Detection Market size in 2031 will be US$ 7426 million.

Who are the main players in the Hematologic Malignancies Detection Market report?

Ans: The main players in the Hematologic Malignancies Detection Market are ArcherDx, Bio-Rad Laboratories, sysmex, Invitae, NeoGenomics Laboratories, Abbott Laboratories, Cancer Genetics, Adaptive Biotechnologies Corporation, Asuragen, Invivoscribe, Nanjing Shihejiyin Technology, Annaroad Gene Technology, BGI Genomics

What are the Application segmentation covered in the Hematologic Malignancies Detection Market report?

Ans: The Applications covered in the Hematologic Malignancies Detection Market report are Multiple Myeloma, Myelodysplastic Syndrome, Leukemia, Myeloproliferative Neoplasms, Lymphoma, Others

What are the Type segmentation covered in the Hematologic Malignancies Detection Market report?

Ans: The Types covered in the Hematologic Malignancies Detection Market report are Polymerase Chain Reaction, Immunochemistry, Next Generation Sequencing, Fluorescence in Situ Hybridization, Others

Recommended Reports

Hematology Diagnostics

Blood Testing Markets

Hematologic Therapeutics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hematologic Malignancies Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polymerase Chain Reaction

1.2.3 Immunochemistry

1.2.4 Next Generation Sequencing

1.2.5 Fluorescence in Situ Hybridization

1.2.6 Others

1.3 Market by Application

1.3.1 Global Hematologic Malignancies Detection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Multiple Myeloma

1.3.3 Myelodysplastic Syndrome

1.3.4 Leukemia

1.3.5 Myeloproliferative Neoplasms

1.3.6 Lymphoma

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hematologic Malignancies Detection Market Perspective (2020-2031)

2.2 Global Hematologic Malignancies Detection Growth Trends by Region

2.2.1 Global Hematologic Malignancies Detection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Hematologic Malignancies Detection Historic Market Size by Region (2020-2025)

2.2.3 Hematologic Malignancies Detection Forecasted Market Size by Region (2026-2031)

2.3 Hematologic Malignancies Detection Market Dynamics

2.3.1 Hematologic Malignancies Detection Industry Trends

2.3.2 Hematologic Malignancies Detection Market Drivers

2.3.3 Hematologic Malignancies Detection Market Challenges

2.3.4 Hematologic Malignancies Detection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hematologic Malignancies Detection Players by Revenue

3.1.1 Global Top Hematologic Malignancies Detection Players by Revenue (2020-2025)

3.1.2 Global Hematologic Malignancies Detection Revenue Market Share by Players (2020-2025)

3.2 Global Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Hematologic Malignancies Detection Revenue

3.4 Global Hematologic Malignancies Detection Market Concentration Ratio

3.4.1 Global Hematologic Malignancies Detection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hematologic Malignancies Detection Revenue in 2024

3.5 Global Key Players of Hematologic Malignancies Detection Head office and Area Served

3.6 Global Key Players of Hematologic Malignancies Detection, Product and Application

3.7 Global Key Players of Hematologic Malignancies Detection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Hematologic Malignancies Detection Breakdown Data by Type

4.1 Global Hematologic Malignancies Detection Historic Market Size by Type (2020-2025)

4.2 Global Hematologic Malignancies Detection Forecasted Market Size by Type (2026-2031)

5 Hematologic Malignancies Detection Breakdown Data by Application

5.1 Global Hematologic Malignancies Detection Historic Market Size by Application (2020-2025)

5.2 Global Hematologic Malignancies Detection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Hematologic Malignancies Detection Market Size (2020-2031)

6.2 North America Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Hematologic Malignancies Detection Market Size by Country (2020-2025)

6.4 North America Hematologic Malignancies Detection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hematologic Malignancies Detection Market Size (2020-2031)

7.2 Europe Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Hematologic Malignancies Detection Market Size by Country (2020-2025)

7.4 Europe Hematologic Malignancies Detection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hematologic Malignancies Detection Market Size (2020-2031)

8.2 Asia-Pacific Hematologic Malignancies Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2020-2025)

8.4 Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hematologic Malignancies Detection Market Size (2020-2031)

9.2 Latin America Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Hematologic Malignancies Detection Market Size by Country (2020-2025)

9.4 Latin America Hematologic Malignancies Detection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hematologic Malignancies Detection Market Size (2020-2031)

10.2 Middle East & Africa Hematologic Malignancies Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2020-2025)

10.4 Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 ArcherDx

11.1.1 ArcherDx Company Details

11.1.2 ArcherDx Business Overview

11.1.3 ArcherDx Hematologic Malignancies Detection Introduction

11.1.4 ArcherDx Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.1.5 ArcherDx Recent Development

11.2 Bio-Rad Laboratories

11.2.1 Bio-Rad Laboratories Company Details

11.2.2 Bio-Rad Laboratories Business Overview

11.2.3 Bio-Rad Laboratories Hematologic Malignancies Detection Introduction

11.2.4 Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.2.5 Bio-Rad Laboratories Recent Development

11.3 sysmex

11.3.1 sysmex Company Details

11.3.2 sysmex Business Overview

11.3.3 sysmex Hematologic Malignancies Detection Introduction

11.3.4 sysmex Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.3.5 sysmex Recent Development

11.4 Invitae

11.4.1 Invitae Company Details

11.4.2 Invitae Business Overview

11.4.3 Invitae Hematologic Malignancies Detection Introduction

11.4.4 Invitae Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.4.5 Invitae Recent Development

11.5 NeoGenomics Laboratories

11.5.1 NeoGenomics Laboratories Company Details

11.5.2 NeoGenomics Laboratories Business Overview

11.5.3 NeoGenomics Laboratories Hematologic Malignancies Detection Introduction

11.5.4 NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.5.5 NeoGenomics Laboratories Recent Development

11.6 Abbott Laboratories

11.6.1 Abbott Laboratories Company Details

11.6.2 Abbott Laboratories Business Overview

11.6.3 Abbott Laboratories Hematologic Malignancies Detection Introduction

11.6.4 Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.6.5 Abbott Laboratories Recent Development

11.7 Cancer Genetics

11.7.1 Cancer Genetics Company Details

11.7.2 Cancer Genetics Business Overview

11.7.3 Cancer Genetics Hematologic Malignancies Detection Introduction

11.7.4 Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.7.5 Cancer Genetics Recent Development

11.8 Adaptive Biotechnologies Corporation

11.8.1 Adaptive Biotechnologies Corporation Company Details

11.8.2 Adaptive Biotechnologies Corporation Business Overview

11.8.3 Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Introduction

11.8.4 Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.8.5 Adaptive Biotechnologies Corporation Recent Development

11.9 Asuragen

11.9.1 Asuragen Company Details

11.9.2 Asuragen Business Overview

11.9.3 Asuragen Hematologic Malignancies Detection Introduction

11.9.4 Asuragen Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.9.5 Asuragen Recent Development

11.10 Invivoscribe

11.10.1 Invivoscribe Company Details

11.10.2 Invivoscribe Business Overview

11.10.3 Invivoscribe Hematologic Malignancies Detection Introduction

11.10.4 Invivoscribe Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.10.5 Invivoscribe Recent Development

11.11 Nanjing Shihejiyin Technology

11.11.1 Nanjing Shihejiyin Technology Company Details

11.11.2 Nanjing Shihejiyin Technology Business Overview

11.11.3 Nanjing Shihejiyin Technology Hematologic Malignancies Detection Introduction

11.11.4 Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.11.5 Nanjing Shihejiyin Technology Recent Development

11.12 Annaroad Gene Technology

11.12.1 Annaroad Gene Technology Company Details

11.12.2 Annaroad Gene Technology Business Overview

11.12.3 Annaroad Gene Technology Hematologic Malignancies Detection Introduction

11.12.4 Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.12.5 Annaroad Gene Technology Recent Development

11.13 BGI Genomics

11.13.1 BGI Genomics Company Details

11.13.2 BGI Genomics Business Overview

11.13.3 BGI Genomics Hematologic Malignancies Detection Introduction

11.13.4 BGI Genomics Revenue in Hematologic Malignancies Detection Business (2020-2025)

11.13.5 BGI Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Archerdx

Bio Rad Laboratories

Sysmex

Invitae

Neogenomics Laboratories

Abbott Laboratories

Cancer Genetics

Adaptive Biotechnologies Corporation

Asuragen

Invivoscribe

Annaroad Gene Technology

BGI Genomics

Nanjing Shihejiyin Technology

List of Tables

Table 1. Global Hematologic Malignancies Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polymerase Chain Reaction

Table 3. Key Players of Immunochemistry

Table 4. Key Players of Next Generation Sequencing

Table 5. Key Players of Fluorescence in Situ Hybridization

Table 6. Key Players of Others

Table 7. Global Hematologic Malignancies Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Hematologic Malignancies Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Hematologic Malignancies Detection Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Hematologic Malignancies Detection Market Share by Region (2020-2025)

Table 11. Global Hematologic Malignancies Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Hematologic Malignancies Detection Market Share by Region (2026-2031)

Table 13. Hematologic Malignancies Detection Market Trends

Table 14. Hematologic Malignancies Detection Market Drivers

Table 15. Hematologic Malignancies Detection Market Challenges

Table 16. Hematologic Malignancies Detection Market Restraints

Table 17. Global Hematologic Malignancies Detection Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Hematologic Malignancies Detection Market Share by Players (2020-2025)

Table 19. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2024)

Table 20. Ranking of Global Top Hematologic Malignancies Detection Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Hematologic Malignancies Detection Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Hematologic Malignancies Detection, Headquarters and Area Served

Table 23. Global Key Players of Hematologic Malignancies Detection, Product and Application

Table 24. Global Key Players of Hematologic Malignancies Detection, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Hematologic Malignancies Detection Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Hematologic Malignancies Detection Revenue Market Share by Type (2020-2025)

Table 28. Global Hematologic Malignancies Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Hematologic Malignancies Detection Revenue Market Share by Type (2026-2031)

Table 30. Global Hematologic Malignancies Detection Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Hematologic Malignancies Detection Revenue Market Share by Application (2020-2025)

Table 32. Global Hematologic Malignancies Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Hematologic Malignancies Detection Revenue Market Share by Application (2026-2031)

Table 34. North America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Hematologic Malignancies Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Hematologic Malignancies Detection Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Hematologic Malignancies Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Hematologic Malignancies Detection Market Size by Country (2026-2031) & (US$ Million)

Table 49. ArcherDx Company Details

Table 50. ArcherDx Business Overview

Table 51. ArcherDx Hematologic Malignancies Detection Product

Table 52. ArcherDx Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 53. ArcherDx Recent Development

Table 54. Bio-Rad Laboratories Company Details

Table 55. Bio-Rad Laboratories Business Overview

Table 56. Bio-Rad Laboratories Hematologic Malignancies Detection Product

Table 57. Bio-Rad Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 58. Bio-Rad Laboratories Recent Development

Table 59. sysmex Company Details

Table 60. sysmex Business Overview

Table 61. sysmex Hematologic Malignancies Detection Product

Table 62. sysmex Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 63. sysmex Recent Development

Table 64. Invitae Company Details

Table 65. Invitae Business Overview

Table 66. Invitae Hematologic Malignancies Detection Product

Table 67. Invitae Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 68. Invitae Recent Development

Table 69. NeoGenomics Laboratories Company Details

Table 70. NeoGenomics Laboratories Business Overview

Table 71. NeoGenomics Laboratories Hematologic Malignancies Detection Product

Table 72. NeoGenomics Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 73. NeoGenomics Laboratories Recent Development

Table 74. Abbott Laboratories Company Details

Table 75. Abbott Laboratories Business Overview

Table 76. Abbott Laboratories Hematologic Malignancies Detection Product

Table 77. Abbott Laboratories Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 78. Abbott Laboratories Recent Development

Table 79. Cancer Genetics Company Details

Table 80. Cancer Genetics Business Overview

Table 81. Cancer Genetics Hematologic Malignancies Detection Product

Table 82. Cancer Genetics Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 83. Cancer Genetics Recent Development

Table 84. Adaptive Biotechnologies Corporation Company Details

Table 85. Adaptive Biotechnologies Corporation Business Overview

Table 86. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Product

Table 87. Adaptive Biotechnologies Corporation Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 88. Adaptive Biotechnologies Corporation Recent Development

Table 89. Asuragen Company Details

Table 90. Asuragen Business Overview

Table 91. Asuragen Hematologic Malignancies Detection Product

Table 92. Asuragen Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 93. Asuragen Recent Development

Table 94. Invivoscribe Company Details

Table 95. Invivoscribe Business Overview

Table 96. Invivoscribe Hematologic Malignancies Detection Product

Table 97. Invivoscribe Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 98. Invivoscribe Recent Development

Table 99. Nanjing Shihejiyin Technology Company Details

Table 100. Nanjing Shihejiyin Technology Business Overview

Table 101. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Product

Table 102. Nanjing Shihejiyin Technology Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 103. Nanjing Shihejiyin Technology Recent Development

Table 104. Annaroad Gene Technology Company Details

Table 105. Annaroad Gene Technology Business Overview

Table 106. Annaroad Gene Technology Hematologic Malignancies Detection Product

Table 107. Annaroad Gene Technology Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 108. Annaroad Gene Technology Recent Development

Table 109. BGI Genomics Company Details

Table 110. BGI Genomics Business Overview

Table 111. BGI Genomics Hematologic Malignancies Detection Product

Table 112. BGI Genomics Revenue in Hematologic Malignancies Detection Business (2020-2025) & (US$ Million)

Table 113. BGI Genomics Recent Development

Table 114. Research Programs/Design for This Report

Table 115. Key Data Information from Secondary Sources

Table 116. Key Data Information from Primary Sources

Table 117. Authors List of This Report

List of Figures

Figure 1. Hematologic Malignancies Detection Picture

Figure 2. Global Hematologic Malignancies Detection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hematologic Malignancies Detection Market Share by Type: 2024 VS 2031

Figure 4. Polymerase Chain Reaction Features

Figure 5. Immunochemistry Features

Figure 6. Next Generation Sequencing Features

Figure 7. Fluorescence in Situ Hybridization Features

Figure 8. Others Features

Figure 9. Global Hematologic Malignancies Detection Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Hematologic Malignancies Detection Market Share by Application: 2024 VS 2031

Figure 11. Multiple Myeloma Case Studies

Figure 12. Myelodysplastic Syndrome Case Studies

Figure 13. Leukemia Case Studies

Figure 14. Myeloproliferative Neoplasms Case Studies

Figure 15. Lymphoma Case Studies

Figure 16. Others Case Studies

Figure 17. Hematologic Malignancies Detection Report Years Considered

Figure 18. Global Hematologic Malignancies Detection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Hematologic Malignancies Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Hematologic Malignancies Detection Market Share by Region: 2024 VS 2031

Figure 21. Global Hematologic Malignancies Detection Market Share by Players in 2024

Figure 22. Global Top Hematologic Malignancies Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Hematologic Malignancies Detection Revenue in 2024

Figure 24. North America Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Hematologic Malignancies Detection Market Share by Country (2020-2031)

Figure 26. United States Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Hematologic Malignancies Detection Market Share by Country (2020-2031)

Figure 30. Germany Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Hematologic Malignancies Detection Market Share by Region (2020-2031)

Figure 38. China Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Hematologic Malignancies Detection Market Share by Country (2020-2031)

Figure 46. Mexico Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Hematologic Malignancies Detection Market Share by Country (2020-2031)

Figure 50. Turkey Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Hematologic Malignancies Detection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. ArcherDx Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 54. Bio-Rad Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 55. sysmex Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 56. Invitae Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 57. NeoGenomics Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 58. Abbott Laboratories Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 59. Cancer Genetics Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 60. Adaptive Biotechnologies Corporation Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 61. Asuragen Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 62. Invivoscribe Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 63. Nanjing Shihejiyin Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 64. Annaroad Gene Technology Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 65. BGI Genomics Revenue Growth Rate in Hematologic Malignancies Detection Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Hematologic Malignancies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematologic Malignancies Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematology Oncology Diagnostics Market Research Report 2024

Hematopathology Clinical Laboratory Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematologic Malignancies Treatment Market Research Report 2024

Global Hematologic Oncology Treatment Market Research Report 2024

Global Hematological Cancers Market Research Report 2024

Acute Myeloid Leukemia Biomarker Detection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematology Testing Product Market Research Report 2024

Hematology Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Haemato Oncology Testing Market Research Report 2025

Compact Hematology Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematology Device Market Insights Forecast to 2030

Hematology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematological Malignancies Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hematology and Coagulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hematology Instrument Market Insights Forecast to 2030

Hematology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions